Biologics in Severe Asthma: An Ideal Choice for Achieving Control

被引：0
|
作者：
Kim, Sae-Hoon [1 ,2 ,3 ]
机构：
[1] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea
[2] Seoul Natl Univ, Med Res Ctr, Inst Allergy & Clin Immunol, Seoul, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
来源：
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH | 2024年 / 16卷 / 03期
关键词：
ALLERGY;
D O I：
10.4168/aair.2024.16.3.214
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：214 / 216
页数：3
相关论文
共 50 条
  • [21] Biologics for severe asthma: control and quality of life in real-life settings
    Maio, Sara
    Baldacci, Sandra
    Viegi, Giovanni
    Pistelli, Francesco
    Vagaggini, Barbara
    Iacopini, Elisa
    Braschi, Maria Chiara
    Bilo, Maria Beatrice
    Carrozzi, Laura
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [22] Do older patients with severe asthma respond to asthma biologics?
    Soe, Wint Wah
    Mittal, Rahul
    Cook, Peter
    Eames, Chellan
    Kerley, Sumita
    Whitfield, Ciara
    Pantaleon, Ma
    McCreery, Jodi
    Freeman, Anna
    Haitchi, Hans Michael
    Kurukulaaratchy, Ramesh
    Dennison, Paddy
    Rupan, Hitasha
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [23] Achieving asthma control
    Barnes, PJ
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 : S5 - S9
  • [24] Criteria for Evaluating Response to Biologics in severe Asthma- the Biologics Asthma Response Score (BARS)
    Milger-Kneidinger, K.
    Korn, S.
    Feder, C.
    Fuge, J.
    Muhle, A.
    Schutte, W.
    Skowasch, D.
    Timmermann, H.
    Suhling, H.
    PNEUMOLOGIE, 2023, 77 : S108 - S108
  • [25] FENOMA Study: Achieving Full Control in Patients with Severe Allergic Asthma
    Cabrejos, Sheila
    Moreira, Ana
    Ramirez, Andreina
    Quirce, Santiago
    Soto Campos, Gregorio
    Davila, Ignacio
    Campo, Paloma
    JOURNAL OF ASTHMA AND ALLERGY, 2020, 13 : 159 - 166
  • [26] Efficacy of biologics for severe asthma on allergic comorbidities
    de Menonville, C. Thibaut
    Barakat, L.
    Laborier, F.
    Le Brun, M.
    Dupin, C.
    Neukirch, C.
    Taille, C.
    REVUE DES MALADIES RESPIRATOIRES, 2024, 41 (09) : 669 - 679
  • [27] Severe asthma and eligibility for biologics in a Brazilian cohort
    Marques Mello, Luane
    Viana, Karynna P.
    Moraes dos Santos, Felipe
    Saturnino, Luciana T. M.
    Kormann, Michelle L.
    Lazaridis, Evelyn
    Torreao, Cinthia D.
    Soares, Claudia R.
    Abreu, Gabriela A.
    de Lima, Valmar Biao
    Pinheiro, Gabriela P.
    Lima-Matos, Aline
    Ponte, Eduardo Vieira
    Mohan, Divya
    Riley, John H.
    Cruz, Alvaro A.
    JOURNAL OF ASTHMA, 2021, 58 (07) : 958 - 966
  • [28] Biologics for the Treatments of Allergic Conditions Severe Asthma
    Caminati, Marco
    Bagnasco, Diego
    Rosenwasser, Lanny J.
    Vianello, Andrea
    Senna, Gianenrico
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2020, 40 (04) : 549 - 564
  • [29] COVID-19, severe asthma, and biologics
    Garcia-Moguel, Ismael
    Campos, Rocio Diaz
    Charterina, Sergio Alonso
    Rodriguez, Consuelo Fernandez
    Crespo, Jesus Fernandez
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (03) : 357 - 359
  • [30] Frequency and reasons for biologics switching in severe asthma
    Gerstlauer, M.
    Seefeldt, M.
    Buhl, R.
    Hamelmann, E.
    Taube, C.
    Idzko, M.
    Korn, S.
    PNEUMOLOGIE, 2022, 76 : S31 - S31
12345